Literature DB >> 32511726

Intraindividual variability in sleep schedule: effects of an internet-based cognitive-behavioral therapy for insomnia program and its relation with symptom remission.

Kelly M Shaffer1, Donald Hedeker2, Charles M Morin3, Karen Ingersoll1, Frances Thorndike4, Lee M Ritterband1.   

Abstract

STUDY
OBJECTIVES: Sleep schedule consistency is fundamental to cognitive-behavioral therapy for insomnia (CBT-I), although there is limited evidence suggesting whether it predicts treatment response. This analysis tested whether: (1) an Internet-based CBT-I program affects intraindividual variability (IIV) in sleep schedule and (2) sleep schedule IIV predicts insomnia symptom remission.
METHODS: This secondary analysis compares participants (N = 303) randomized to an Internet-based CBT-I program (SHUTi-Sleep Healthy Using the Internet) or Internet-based patient education (PE). Participants reported daily bedtimes and rising times on 10 online sleep diaries collected over 2 weeks at baseline and 9-week post-intervention assessment. Participants completed the Insomnia Severity Index (ISI) at post-assessment and 6-month follow-up; symptom remission was defined by ISI < 8. Mixed effects location scale modeling was used to examine the effect of SHUTi on bedtime and rising time IIV; a novel two-staged analysis examined the effect of bedtime and rising time IIV on insomnia symptom remission.
RESULTS: At post-assessment, SHUTi participants reported about 30% less bedtime and 32% less rising time variability compared to PE (ps < 0.03). Bedtime and rising time IIV was not independently associated with likelihood of insomnia symptom remission at the subsequent time point (ps > 0.18), nor did sleep schedule IIV moderate treatment response (ps > 0.12).
CONCLUSIONS: Findings demonstrate that an Internet-delivered CBT-I program can effectively increase users' sleep schedule consistency relative to an educational control. This consistency, however, was not related to treatment outcome when defined by insomnia symptom remission, suggesting that enforcing rigid sleep schedules for patients may not be necessary for treatment success. CLINICAL TRIAL REGISTRATION: NCT00328250. © Sleep Research Society 2020. Published by Oxford University Press on behalf of the Sleep Research Society. All rights reserved. For permissions, please e-mail journals.permissions@oup.com.

Entities:  

Keywords:  cognitive therapy; internet; intraindividual variability; personalized medicine; risk factors; sleep initiation and maintenance disorders; treatment outcome

Mesh:

Year:  2020        PMID: 32511726      PMCID: PMC7734473          DOI: 10.1093/sleep/zsaa115

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  34 in total

Review 1.  Efficacy of internet-delivered cognitive-behavioral therapy for insomnia - A systematic review and meta-analysis of randomized controlled trials.

Authors:  Robert Zachariae; Marlene S Lyby; Lee M Ritterband; Mia S O'Toole
Journal:  Sleep Med Rev       Date:  2015-10-24       Impact factor: 11.609

2.  Proof of Concept for an Adaptive Treatment Strategy to Prevent Failures in Internet-Delivered CBT: A Single-Blind Randomized Clinical Trial With Insomnia Patients.

Authors:  Erik Forsell; Susanna Jernelöv; Kerstin Blom; Martin Kraepelien; Cecilia Svanborg; Gerhard Andersson; Nils Lindefors; Viktor Kaldo
Journal:  Am J Psychiatry       Date:  2019-01-30       Impact factor: 18.112

3.  Sleep and Physiological Dysregulation: A Closer Look at Sleep Intraindividual Variability.

Authors:  Bei Bei; Teresa E Seeman; Judith E Carroll; Joshua F Wiley
Journal:  Sleep       Date:  2017-09-01       Impact factor: 5.849

4.  Development and Perceived Utility and Impact of an Internet Intervention for Insomnia.

Authors:  Frances P Thorndike; Drew K Saylor; Elaine T Bailey; Linda Gonder-Frederick; Charles M Morin; Lee M Ritterband
Journal:  E J Appl Psychol       Date:  2008

5.  Clinical significance of night-to-night sleep variability in insomnia.

Authors:  Sooyeon Suh; Sara Nowakowski; Rebecca A Bernert; Jason C Ong; Allison T Siebern; Claire L Dowdle; Rachel Manber
Journal:  Sleep Med       Date:  2012-02-20       Impact factor: 3.492

6.  Empirical validation of the Insomnia Severity Index in cancer patients.

Authors:  Marie-Hélène Savard; Josée Savard; Sébastien Simard; Hans Ivers
Journal:  Psychooncology       Date:  2005-06       Impact factor: 3.894

7.  Circadian Phase and Phase Angle Disorders in Primary Insomnia.

Authors:  Erin E Flynn-Evans; Julia A Shekleton; Belinda Miller; Lawrence J Epstein; Douglas Kirsch; Lauren A Brogna; Liza M Burke; Erin Bremer; Jade M Murray; Philip Gehrman; Shantha M W Rajaratnam; Steven W Lockley
Journal:  Sleep       Date:  2017-12-01       Impact factor: 5.849

8.  Are sleep hygiene practices related to the incidence, persistence and remission of insomnia? Findings from a prospective community study.

Authors:  Markus Jansson-Fröjmark; Jonas Evander; Sven Alfonsson
Journal:  J Behav Med       Date:  2018-07-11

9.  The association between sleep patterns and obesity in older adults.

Authors:  S R Patel; A L Hayes; T Blackwell; D S Evans; S Ancoli-Israel; Y K Wing; K L Stone
Journal:  Int J Obes (Lond)       Date:  2014-01-24       Impact factor: 5.095

10.  Validation of the Sleep Regularity Index in Older Adults and Associations with Cardiometabolic Risk.

Authors:  Jessica R Lunsford-Avery; Matthew M Engelhard; Ann Marie Navar; Scott H Kollins
Journal:  Sci Rep       Date:  2018-09-21       Impact factor: 4.379

View more
  2 in total

1.  The Impact of Cognitive Behavioral Therapy for Insomnia on Sleep Log and Actigraphy Outcomes in People with Multiple Sclerosis: A Secondary Analysis.

Authors:  Cierra Williams-Cooke; Leslie LeSuer; Michelle Drerup; Catherine Siengsukon
Journal:  Nat Sci Sleep       Date:  2021-10-12

Review 2.  Perinatal Insomnia and Mental Health: a Review of Recent Literature.

Authors:  Leslie M Swanson; David A Kalmbach; Greta B Raglan; Louise M O'Brien
Journal:  Curr Psychiatry Rep       Date:  2020-10-26       Impact factor: 8.081

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.